AnxA1 exerts anti-inflammatory and pro-resolving actions in IBD by modulating cytokine responses, preserving epithelial integrity, and promoting mucosal healing, as shown in Figure 4B. The gene discussed is ANXA1; the disease is irritable bowel syndrome.